axicabtagene ciloleucel
gilead sciences
['dlbcl', 'zuma-7']
jason westin, md, facp, leader, dlbcl research team, md anderson cancer center, discussed results from the zuma-7 trial at #asco22 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.